Doctor profile · Federal record
Dr. KARINA MARIANNE TORRALBA, MD
Rheumatology Physician · Rheumatology Physician · LOS ANGELES, CA
- NPI 1588671176
- MIPS 76.4 / 100 · 2023
- 20 yrs on file
- Licensed in 2 states
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
1520 SAN PABLO ST, SUITE 1000
LOS ANGELES, CA 900335310
(323) 442-1946
fax (323) 442-2874 - Mailing address
-
PO BOX 31309
LOS ANGELES, CA 900310309
Credentials & registration
- NPI registered
- August 2006 — 20 yrs on file
- Profile last updated
- April 24, 2012
- Specialty taxonomy
- 207RR0500X — NUCC code
- State licenses (2)
- California #A73731 · Arkansas #E-4885
- Medicaid
- AR #162910001
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1588671176. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
240
Distinct HCPCS
5
Medicare allowed
$35,066
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 114 | 74 | $131 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 59 | 40 | $185 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 31 | 27 | $176 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 20 | 11 | $81 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 16 | 16 | $132 |
In context: peer comparison
Among 20 peers in this city , average services per provider: 599. This provider delivers 0.4× the peer median.Open Payments
Industry payments received
All-time total
$56,958
Transactions
64
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 36 | $29,440.11 | |
| GENZYME CORPORATION | 16 | $18,071.11 | |
| Aurinia Pharma U.S., Inc. | 7 | $6,134.24 | |
| Fresenius Kabi USA, LLC | 1 | $2,250.00 | |
| Amgen Inc. | 1 | $800.00 | |
| GlaxoSmithKline, LLC. | 1 | $123.37 | |
| ABBVIE INC. | 1 | $111.64 | |
| PFIZER INC. | 1 | $27.11 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
487
Patients
95
Total drug cost
$1,467,164
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Methotrexate (Methotrexate Sodium) | Brand | 78 | 29 | $2,660 |
| Hydroxychloroquine Sulfate | Generic | 77 | 29 | $5,192 |
| Prednisone | Generic | 53 | 26 | $703 |
| Rinvoq (Upadacitinib) | Brand | 48 | 0 | $321,689 |
| Leflunomide | Generic | 33 | 11 | $2,536 |
| Leucovorin Calcium | Generic | 32 | 0 | $441 |
| Humira(Cf) Pen (Adalimumab) | Brand | 31 | 0 | $230,122 |
| Enbrel Sureclick (Etanercept) | Brand | 29 | 0 | $241,012 |
| Orencia (Abatacept/Maltose) | Brand | 25 | 0 | $100,500 |
| Tavneos (Avacopan) | Brand | 18 | 0 | $285,588 |